The Salamander Factor
In high school, I came across a short story in our “Rapid Reader” series called “The Salamander Factor.”
A gifted surgeon loses the use of his hands. His identity, his purpose, everything he’d built, gone. Then, inspired by the salamander’s extraordinary ability to regenerate lost limbs, he finds a way to rebuild his own capabilities from scratch. The story stayed with me because of the question it planted: what if biology itself wasn’t the ceiling?
That was fiction then. I’m not sure it is anymore.
Paul Conyngham, a tech entrepreneur in Sydney, learned his dog Rosie had cancer. Tumors persisted through chemotherapy and surgery. So he turned to ChatGPT, which pointed him toward immunotherapy and the University of New South Wales. He used AlphaFold to identify mutated proteins. He convinced researchers to help, funded the genomic sequencing himself, and within two months a bespoke mRNA cancer vaccine had been designed and administered. Rosie’s tumors shrank by 75%. Six weeks post-treatment, she jumped a fence chasing a rabbit.
This is the first personalized cancer vaccine ever designed for a dog, and the learnings will inform human medicine.
The reaction from the people building these tools was immediate.
Greg Brockman, President of OpenAI, highlighted the case publicly: AI had empowered Conyngham to create a custom mRNA vaccine when Rosie had only months to live.
Demis Hassabis, CEO of Google DeepMind and Nobel laureate whose AlphaFold modeled the mutated proteins that made the vaccine possible, called it an early example of “digital biology.”
Aravind Srinivas of Perplexity called AlphaFold one of the greatest outcomes to come from AI.
And Kevin Weil, OpenAI’s CPO, has been building what he describes as “the next great scientific instrument: an AI-powered platform that accelerates scientific discovery.” Rosie is exactly the kind of case that platform exists to make possible.
What strikes me is the architecture of how this happened.
A non-medical engineer, armed with AI tools and genuine urgency, walked into a frontier that credentialed institutions hadn’t yet reached. Not because the institutions lacked capability, but because no one had reason to combine these particular pieces in this particular moment for this particular patient.
That’s the signal. AI doesn’t just accelerate what experts already do. It compresses the distance between a motivated human and a breakthrough that would otherwise require years of institutional scaffolding.
The salamander doesn’t wait for permission to regenerate. It just begins.
We are entering a period where the barriers between “patient” and “researcher,” between “problem” and “solution,” between aspiration and capability, are collapsing faster than our frameworks can track. The human premium here isn’t diminished by AI.
It’s what activates it. Conyngham’s judgment, his refusal to accept a terminal framing, his willingness to learn and connect and ask, that’s what made the tools matter.
Personalized medicine. Personalized learning. Personalized infrastructure. Each a version of the same idea: intelligence, made specific to you, at the moment you need it.
The salamander factor isn’t fiction anymore. Until next time,
Ram
—
Ram Srinivasan
MIT Alum | Author, The Conscious Machine | Global Future of Work and AI Adoption Leader published in Business Insider, Fortune, Harvard Business Review, MIT Executive Viewpoints and more.
—
A Message From Ram:
My mission is to illuminate the path toward humanity's exponential future. If you're a leader, innovator, or changemaker passionate about leveraging breakthrough technologies to create unprecedented positive impact, you're in the right place. If you know others who share this vision, please share these insights. Together, we can accelerate the trajectory of human progress.
Disclaimer:
Ram Srinivasan currently serves as an Innovation Strategist and Transformation Leader, authoring groundbreaking works including "The Conscious Machine" and the upcoming "The Exponential Human."
All views expressed on "Substrate" and across all digital channels and social media platforms are strictly personal opinions and do not represent the official positions of any organizations or entities I am affiliated with, past or present. The content shared is for informational and inspirational purposes only. These perspectives are my own and should not be construed as professional, legal, financial, technical, or strategic advice. Any decisions made based on this information are solely the responsibility of the reader.
While I strive to ensure accuracy and timeliness in all communications, the rapid pace of technological change means that some information may become outdated. I encourage readers to conduct their own due diligence and seek appropriate professional advice for their specific circumstances.
